Bavarian Nordic to Develop Biodefense Vaccine
Blood culture of burkholderia pseudomallei, the causative agent of melioidosis. Credit: CDC/Larry Stauffer The Defense Threat Reduction Agency (DTRA) has ...
Tag: Poxviruses
Emergent Expands Biodefense Holdings with Acquisition of Cangene
Emergent BioSolutions, which has long supplied the U.S. federal government with anthrax vaccine, last week announced a definitive agreement with Cangene ...
Bavarian Nordic Completes Smallpox Vaccine Delivery to SNS
Bavarian Nordic recently announced it completed the delivery of 20 million doses of IMVAMUNE smallpox biodefense vaccine to the U.S. ...
Navy Seeks CBRE Mail Screening Equipment
The U.S. Department of the Navy is soliciting for commercial Chemical Biological Radiation Explosive and Narcotic (CBRE-N) Freight X-Ray Mail ...
The Evolving Nature of Synthetic Biology: A Panel Discussion on Key Science, Policy, and Societal Challenges Facing the International Community
Remarks given by E. William Colglazier, Ph.D., Science and Technology Adviser to the Secretary Jonathan Margolis, Acting Deputy Assistant Secretary, ...
PharmAthene and Theraclone Sciences Announce Merger Agreement
Biodefense therapeutics developer PharmAthene, Inc. and Theraclone Sciences, Inc., a privately-held monoclonal antibody (mAb) discovery and development company, last week ...
SIGA Makes Third Delivery of Smallpox Drug for Biodefense Stockpile
SIGA Technologies, Inc. this week announced it has passed another significant milestone with the third delivery of its proprietary smallpox antiviral ...
NHRC, Mayo Clinic Study Immune Response Following Smallpox Vaccination
In collaboration with Dr. Gregory Poland at the Vaccine Research Group at the Mayo Clinic, researchers from the Naval Health ...
SIGA Begins Smallpox Drug Shipments to National Stockpile
SIGA Technologies this week announced the first of a series of deliveries of its proprietary smallpox antiviral drug, Arestvyr (formerly ...
CDC: Transmission of Vaccinia Virus After Sexual Contact with Recent Vaccinee
The Centers for Disease Control published details this week on an interesting epidemiological case of a man in San Diego ...
10 Biodefense Breakthroughs We’re Thankful For
As our readers in the U.S. celebrate Thanksgiving Day, we pause to acknowledge several historic milestones that changed the landscape ...
Funding Award for a Combined Smallpox-Marburg Vaccine
Danish drug maker Bavarian Nordic this week announced an award from the U.S. government, valued at up $18 million over ...
Accelerating Immune Response to Biodefense Vaccines
The deadline is fast approaching for companies to submit proposals towards advanced development of medical countermeasures for use in settings following ...
SIGA Ordered to Share Biodefense Contract Profits with PharmAthene
Last week a Delaware Court of Chancery issued its final judgment in litigation spanning over 5 years brought by PharmAthene, ...
Smallpox Drug Gets Funding Boost from HHS
The Department of Health and Human Services (HHS) has supported the initiation of an expanded Phase 3 study of the ...
DTRA Funds Biothreat Research Projects in Central Africa
The Defense Threat Reduction Agency (DTRA) intends to award a sole source contract to Global Viral Forecasting, Inc. (GVF) to ...
